
### [NCIT:C4015](http://purl.obolibrary.org/obo/NCIT_C4015)
**Label:** Metastatic Malignant Neoplasm in the Central Nervous System

**Subclasses:** [NCIT:C133501](http://purl.obolibrary.org/obo/NCIT_C133501) (Breast Carcinoma Metastatic in the Central Nervous System), [NCIT:C114950](http://purl.obolibrary.org/obo/NCIT_C114950) (Secondary Central Nervous System Non-Hodgkin Lymphoma), [NCIT:C5057](http://purl.obolibrary.org/obo/NCIT_C5057) (Metastatic Hodgkin Lymphoma in the Cerebral Hemisphere), [NCIT:C4585](http://purl.obolibrary.org/obo/NCIT_C4585) (Metastatic Malignant Neoplasm in the Spinal Cord), [NCIT:C8550](http://purl.obolibrary.org/obo/NCIT_C8550) (Metastatic Malignant Neoplasm in the Brain Stem), [NCIT:C87797](http://purl.obolibrary.org/obo/NCIT_C87797) (Secondary Central Nervous System Lymphoma), [NCIT:C36304](http://purl.obolibrary.org/obo/NCIT_C36304) (Lung Carcinoma Metastatic in the Brain), [NCIT:C133503](http://purl.obolibrary.org/obo/NCIT_C133503) (Lung Carcinoma Metastatic in the Central Nervous System), [NCIT:C133504](http://purl.obolibrary.org/obo/NCIT_C133504) (Melanoma Metastatic in the Central Nervous System), [NCIT:C36301](http://purl.obolibrary.org/obo/NCIT_C36301) (Breast Carcinoma Metastatic in the Brain), [NCIT:C3813](http://purl.obolibrary.org/obo/NCIT_C3813) (Metastatic Malignant Neoplasm in the Brain), [NCIT:C5816](http://purl.obolibrary.org/obo/NCIT_C5816) (Metastatic Malignant Neoplasm in the Adult Brain), [NCIT:C114949](http://purl.obolibrary.org/obo/NCIT_C114949) (Secondary Central Nervous System Hodgkin Lymphoma), 

**Class expressions from DL-Learner:**

- [UBERON:0001017](http://purl.obolibrary.org/obo/UBERON_0001017) (central nervous system) 58.33%
- [UBERON:0001016](http://purl.obolibrary.org/obo/UBERON_0001016) (nervous system) 58.33%
- [NCIT:C41444](http://purl.obolibrary.org/obo/NCIT_C41444) (Secondary Lesion) 58.33%
- [NCIT:C40557](http://purl.obolibrary.org/obo/NCIT_C40557) (Metastatic Lesion) 58.33%
- [NCIT:C36105](http://purl.obolibrary.org/obo/NCIT_C36105) (Indolent Clinical Course) 58.33%
- Thing 51.96%
- [NCIT:C3367](http://purl.obolibrary.org/obo/NCIT_C3367) (Finding) 28.10%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 27.64%
- [NCIT:C3824](http://purl.obolibrary.org/obo/NCIT_C3824) (Lesion) 25.58%
- [BFO:0000040](http://purl.obolibrary.org/obo/BFO_0000040) (material entity) 18.82%
- [UBERON:0001062](http://purl.obolibrary.org/obo/UBERON_0001062) (anatomical entity) 18.81%
- [BFO:0000004](http://purl.obolibrary.org/obo/BFO_0000004) (null) 18.68%
- [BFO:0000002](http://purl.obolibrary.org/obo/BFO_0000002) (null) 18.68%
- [NCIT:C35461](http://purl.obolibrary.org/obo/NCIT_C35461) (Clinical Course of Disease) 17.04%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) 11.57%


